| Anticancer Fund

ReDO: selective PDE5 inhibitors as anti-cancer agents

Pantziarka, P., Sukhatme, V., Crispino, S., Bouche, G., Meheus, L., & Sukhatme, V. P. (2018). Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents. Ecancermedicalscience, 12, 824. doi:10.3332/ecancer.2018.824

Wed, 04/11/2018 - 12:00

Repurposing non-cancer drugs for breast cancer? An emerging opportunity.

presented on EBCC-11 by our colleague Sergio Crispino

Wed, 03/21/2018 - 12:00

11th European Breast Cancer Conference

21 – 23 March 2018 | Barcelona, Spain

Wed, 03/21/2018 - 12:00

Cancer groundshot: going global before going to the moon

Bishal Gyawali, Richard Sullivan, Christopher M Booth. Cancer groundshot: going global before going to the moon. The Lancet Oncology, 2018 Mar;19(3):288-290. doi: 10.1016/S1470-2045(18)30076-7

Sun, 03/18/2018 - 12:00

European Training School in Perioperative Care of the Cancer Patient

Fri, 03/09/2018 - 12:00

Roundtable at the European Parliament

27 February 2018 | Brussels, Belgium

Tue, 02/27/2018 - 12:00

ASPIRINE ALS BEHANDELING TEGEN DARMKANKER - patiëntonderzoek in Vlaanderen van start

Tue, 02/27/2018 - 12:00

Announcement on the ASPIRIN trial

Wed, 01/10/2018 - 12:00